-
Monodispersed PEGs
- >Methoxy PEG (mPEG)
- >Azide(N3) PEG
- >Amine(NH2) PEG
- >Hydroxyl(OH) PEG
- >Thiol(SH) PEG
- >Boc/Fmoc PEG
- >Carboxylic Acid(COOH) PEG
- >Maleimide(Mal) PEG
- >NHS ester PEG
- >Biotin PEG
- >Aldehyde (Ald/CHO)PEG
- >Acrylate(AC) PEG
- >Acrylamide(ACA) PEG
- >DBCO PEG
- >DSPE PEG
- >Other Lipid PEG
- >Fluorescent (FITC) PEG
- >Rhodamine B(RB) PEG
- >Cholesterol PEG
- >OPSS PEG
- >Epoxide (EPO) PEG
- >Hydrazide (HZ) PEG
- >Folic Acid(FA) PEG
- >Lipoic acid(LA) PEG
- >Methacrylate (MA) PEG
- >Silane PEG
- >PEG Sulfonic acid
- >PEG PFP ester
- >PEG TFP ester
- >Halide (F,Cl,Br,I) PEG
- >Benzyl-PEG
- >Aminooxy PEG
- >Hydrocarbons PEG
- >Nitrophenyl Carbonate (NPC) PEG
- >DNP PEG
- >Other PEG
- >PROTAC Linker
- >View More
-
Polydispersed PEGs
- >Methoxy PEG (mPEG)
- >Azide(N3) PEG
- >Amine(NH2) PEG
- >Hydroxyl(OH) PEG
- >Thiol(SH) PEG
- >DSPE PEG
- >Carboxylic Acid(COOH) PEG
- >Maleimide(Mal) PEG
- >NHS ester PEG
- >Other Lipid PEG
- >Acrylate(AC) PEG
- >Boc/Fmoc PEG
- >Biotin PEG
- >Aldehyde (Ald/CHO)PEG
- >Fluorescent (FITC) PEG
- >Cyanine (Cy) PEG
- >Rhodamine B(RB) PEG
- >Cholesterol PEG
- >OPSS PEG
- >Acrylamide(ACA) PEG
- >Epoxide (EPO) PEG
- >Hydrazide (HZ) PEG
- >Folic Acid(FA) PEG
- >Lipoic acid(LA) PEG
- >Methacrylate (MA) PEG
- >Silane PEG
- >PLGA PEG
- >PCL PEG
- >PLA PEG
- >PEG Sulfonic acid
- >PEG PFP ester
- >Halide (F,Cl,Br,I) PEG
- >Aminooxy PEG
- >DBCO PEG
- >Hydrocarbons PEG
- >Nitrophenyl Carbonate (NPC) PEG
- >Other PEG
- >View More
-
Multi-arm PEGs
- >Hydroxyl(OH) PEG
- >NHS ester PEG
- >Amine(NH2) PEG
- >Maleimide(Mal) PEG
- >Azide(N3) PEG
- >Thiol(SH) PEG
- >DBCO PEG
- >Carboxylic Acid(COOH) PEG
- >Aldehyde (Ald/CHO)PEG
- >Methoxy PEG (mPEG)
- >Acrylate(AC) PEG
- >Biotin PEG
- >Cholesterol PEG
- >OPSS PEG
- >Acrylamide(ACA) PEG
- >Epoxide (EPO) PEG
- >Hydrazide (HZ) PEG
- >Folic Acid(FA) PEG
- >Lipoic acid(LA) PEG
- >Methacrylate (MA) PEG
- >Silane PEG
- >Halide (F,Cl,Br,I) PEG
- >Hydrocarbons PEG
- >Nitrophenyl Carbonate (NPC) PEG
- >Other PEG
- >View More
- PEGs by Application
- Lipids for Lipid Nanoparticles
- PEG Raw Material
CatalogID: 10085 Purity: ≥95%
-
Synonyms:
Maleimide-PEG-Amine
-
Purity:
≥95% -
Recommended Storage Condition:
Store at -5°C,keep in dry and avoid sunlight. -
Uses:
Applicated in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.
Maleimide-PEG-Amine (Mal-PEG-NH2) is a linear heterobifunctional PEG linker that is generally employed as crosslinking agents or as spacers between two different chemical entities.
Cited Publications
This PEG derivative has been cited in peer-reviewed scientific publications. Browse the references below to learn more.
- Lee, J. R., Kim, Y. M., Kim, E. J., Jang, M. K., & Park, S. C. (2024). Advancing Breast Cancer Therapeutics: Targeted Gene Delivery Systems Unveiling the Potential of Estrogen Receptor-Targeting Ligands. Biomaterials research, 28, 0087. https://doi.org/10.34133/bmr.0087
- Moura, R. P., Carvalho, E. D., Martins, C., Des Rieux, A., Pêgo, A. P., & Sarmento, B. (2023). Functionalized retinoic acid lipid nanocapsules promotes a two-front attack on inflammation and lack of demyelination on neurodegenerative disorders. Journal of Controlled Release, 358, 43-58. https://doi.org/10.1016/j.jconrel.2023.04.034
- Kim, J., Kim, J. S., Min, K. H., Kim, Y., & Chen, X. (2021). Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery. Bioengineering, 8(4), 43. https://doi.org/10.3390/bioengineering8040043
- Lourenço, B. N., Pereira, R. F., Barrias, C. C., Fischbach, C., Oliveira, C., & Granja, P. L. (2021). Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells. Nanomaterials, 11(2), 295. https://doi.org/10.3390/nano11020295
- Martins, C., Araújo, F., Gomes, M. J., Fernandes, C., Nunes, R., Li, W., Santos, H. A., Borges, F., & Sarmento, B. (2019). Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy. European Journal of Pharmaceutics and Biopharmaceutics, 138, 111-124. https://doi.org/10.1016/j.ejpb.2018.01.014
View more publications citing Biopharma PEG products.

Cat.No:LP101050
Cat.No:HE008005
Cat.No:HE090050
Cat.No:HE022050
Cat.No:FL005290
Cat.No:NE12458
Cat.No:FL296005